"What has been learned from the initial observational phase of CCSVI treatment is informative and should not be wholesale discounted. For example, it is now apparent that after endovascular therapy, certain constitutional or general symptoms common to MS patients, such as fatigue, heat intolerance, clouded cognition, urinary problems, cold distal extremities etc., respond in a tempo that ranges from hours to days." Dr. Michael Dake on the measurable, objective benefits he has documented in treatment for CCSVI--that the Canadian health minister and head neurologist have discounted as merely "well-being."


CCSVI is real, and IRs should treat it with venoplasty---Dr. Michael Dake
(The complete article from the CIRSE conference) link   Michael Dake Stanford University School of Medicine Stanford, California, USA ...